======= PCIF1 ======= == Gene Information == * **Official Symbol**: PCIF1 * **Official Name**: PDX1 C-terminal inhibiting factor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=63935|63935]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H4Z3|Q9H4Z3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PCIF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PCIF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618626|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May play a role in transcription elongation or in coupling transcription to pre-mRNA processing through its association with the phosphorylated C-terminal domain (CTD) of RNAPII largest subunit. |WW| |PCIF1 WW| |mRNA (2-O-methyladenosine-N6-)-methyltransferase activity| |RNA polymerase II C-terminal domain binding| |S-adenosyl-L-methionine binding| |mRNA methylation| |mRNA modification| |intercellular bridge| |RNA methylation| |negative regulation of phosphatase activity| |negative regulation of dephosphorylation| |positive regulation of translation| |positive regulation of cellular amide metabolic process| |microtubule cytoskeleton| |RNA modification| |regulation of phosphatase activity| |regulation of dephosphorylation| |macromolecule methylation| |methylation| |regulation of translation| |regulation of cellular amide metabolic process| |negative regulation of hydrolase activity| |posttranscriptional regulation of gene expression| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |mRNA metabolic process| |negative regulation of catalytic activity| |negative regulation of molecular function| |regulation of hydrolase activity| |positive regulation of cellular protein metabolic process| |RNA metabolic process| |positive regulation of protein metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.31| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|-2.25| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.22| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-2.17| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.15| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.05| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.98| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-1.79| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.76| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.75| |[[:results:exp340|BN82002 4μM R07 exp340]]|-1.7| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.71| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|1.77| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.78| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.79| |[[:results:exp274|Citral 50μM R06 exp274]]|1.8| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.8| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.87| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|1.91| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.98| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.99| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|1.99| |[[:results:exp433|LJH685 50μM R08 exp433]]|2.03| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|2.03| |[[:results:exp275|Citral 75μM R06 exp275]]|2.04| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.04| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.12| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.16| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.25| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.35| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.44| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.47| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|2.65| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|2.71| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.86| |[[:results:exp485|GSK626616 14μM R08 exp485]]|3.48| ^Gene^Correlation^ |[[:human genes:p:pmaip1|PMAIP1]]|0.416| |[[:human genes:z:zfc3h1|ZFC3H1]]|0.415| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10593 * **Expression level (log2 read counts)**: 5.39 {{:chemogenomics:nalm6 dist.png?nolink |}}